Leteprinim is primarily researched for its potential neuroprotective properties, making it a candidate for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's. Its mechanism of action involves reducing oxidative stress and inflammation in neural tissues, which are key factors in the progression of these diseases. Additionally, Leteprinim has been explored for its ability to enhance cognitive function and memory in preclinical studies. Researchers are also investigating its potential use in mitigating the effects of stroke and other brain injuries by promoting neuronal survival and recovery. While still in the experimental stages, Leteprinim holds promise as a therapeutic agent in neurology and brain health.